Review



transfection lipid reagent  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Bio-Rad transfection lipid reagent
    Transfection Lipid Reagent, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 530 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/transfection lipid reagent/product/Bio-Rad
    Average 96 stars, based on 530 article reviews
    transfection lipid reagent - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    96
    Mirus Bio mrna lipid transfection reagent
    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h <t>post-transfection.</t> Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).
    Mrna Lipid Transfection Reagent, supplied by Mirus Bio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mrna lipid transfection reagent/product/Mirus Bio
    Average 96 stars, based on 1 article reviews
    mrna lipid transfection reagent - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Bio-Rad transfection lipid reagent
    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h <t>post-transfection.</t> Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).
    Transfection Lipid Reagent, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/transfection lipid reagent/product/Bio-Rad
    Average 96 stars, based on 1 article reviews
    transfection lipid reagent - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology hieff transtm lipid based transfection reagent
    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h <t>post-transfection.</t> Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).
    Hieff Transtm Lipid Based Transfection Reagent, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hieff transtm lipid based transfection reagent/product/Yeasen Biotechnology
    Average 86 stars, based on 1 article reviews
    hieff transtm lipid based transfection reagent - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology lipid transfection reagent
    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h <t>post-transfection.</t> Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).
    Lipid Transfection Reagent, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lipid transfection reagent/product/Yeasen Biotechnology
    Average 86 stars, based on 1 article reviews
    lipid transfection reagent - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    97
    Mirus Bio cationic lipid polymer transfection reagent trans it tm 2020
    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h <t>post-transfection.</t> Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).
    Cationic Lipid Polymer Transfection Reagent Trans It Tm 2020, supplied by Mirus Bio, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cationic lipid polymer transfection reagent trans it tm 2020/product/Mirus Bio
    Average 97 stars, based on 1 article reviews
    cationic lipid polymer transfection reagent trans it tm 2020 - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    96
    Bio-Rad silentfecttm lipid transfection reagent
    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h <t>post-transfection.</t> Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).
    Silentfecttm Lipid Transfection Reagent, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/silentfecttm lipid transfection reagent/product/Bio-Rad
    Average 96 stars, based on 1 article reviews
    silentfecttm lipid transfection reagent - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h post-transfection. Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).

    Journal: Cell reports

    Article Title: A ribosome-bound pseudoknot in the HCV coding region stimulates viral growth by tuning viral translation

    doi: 10.1016/j.celrep.2025.116739

    Figure Lengend Snippet: (A) Schematic of the WT pseudoknot and structure-disrupting mutants. (B) Luciferase activity of IRES-driven constructs measured over time; construct designs shown on the left. (C) Normalized luciferase activity of various IRES-driven constructs at different time points, relative to the random control; construct designs shown on the left. (D) Workflow for full-length HCV growth assay. (E) Measurement of WT and mutant viral growth by luciferase activity at 24, 48, and 72 h post-transfection. Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).

    Article Snippet: 3 × 10 6 Huh7.5 cells were plated in a 10 cm dish and transfected with 15.5 μg of full-length HCV RNA or mutant RNA using Mirus mRNA lipid transfection reagent (MIR-2250) according to the manufacturer’s protocol.

    Techniques: Luciferase, Activity Assay, Construct, Control, Growth Assay, Mutagenesis, Transfection

    (A–C) Top: Schematic of the dual luciferase constructs used to test pk1’s regulation of upstream and downstream protein expression. Bottom: Gaussia and Firefly luciferase activities for pk1 and random control constructs, measured at 2 h post-transfection and normalized to the random control. (D) qPCR quantification of Actin mRNA or luciferase construct RNA amount relative to 18S rRNA for each sample, normalized to the random control RNA. (E) Left: siRNA knockdown workflow. Right: western blot analysis of ZNF598, GIGYF2, and GAPDH confirming siRNA knockdown efficiency. (F) Gaussia and Firefly luciferase activities after siRNA treatments for pk1 and random control constructs, measured at 2 h post-transfection and normalized to the random control. The inhibitory effect in the siCtrl condition for the pk1-middle construct was weaker than in previous experiments , possibly reflecting variability in RNA input associated with the siRNA transfection setup and limited time point sampling. (G) Graphic showing the proposed pk1 inhibiting translation initiation mechanism. Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).

    Journal: Cell reports

    Article Title: A ribosome-bound pseudoknot in the HCV coding region stimulates viral growth by tuning viral translation

    doi: 10.1016/j.celrep.2025.116739

    Figure Lengend Snippet: (A–C) Top: Schematic of the dual luciferase constructs used to test pk1’s regulation of upstream and downstream protein expression. Bottom: Gaussia and Firefly luciferase activities for pk1 and random control constructs, measured at 2 h post-transfection and normalized to the random control. (D) qPCR quantification of Actin mRNA or luciferase construct RNA amount relative to 18S rRNA for each sample, normalized to the random control RNA. (E) Left: siRNA knockdown workflow. Right: western blot analysis of ZNF598, GIGYF2, and GAPDH confirming siRNA knockdown efficiency. (F) Gaussia and Firefly luciferase activities after siRNA treatments for pk1 and random control constructs, measured at 2 h post-transfection and normalized to the random control. The inhibitory effect in the siCtrl condition for the pk1-middle construct was weaker than in previous experiments , possibly reflecting variability in RNA input associated with the siRNA transfection setup and limited time point sampling. (G) Graphic showing the proposed pk1 inhibiting translation initiation mechanism. Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001).

    Article Snippet: 3 × 10 6 Huh7.5 cells were plated in a 10 cm dish and transfected with 15.5 μg of full-length HCV RNA or mutant RNA using Mirus mRNA lipid transfection reagent (MIR-2250) according to the manufacturer’s protocol.

    Techniques: Luciferase, Construct, Expressing, Control, Transfection, Knockdown, Western Blot, Sampling

    (A) Workflow of polysome fractionation and RNA quantification for HCV-transfected cells. (B) Top: chromatogram showing the separation of monosome and polysome fractions. Middle: distribution of Actin mRNA across all fractions in WT and PUR-treated control. Bottom: distribution of HCV RNA across all fractions in WT virus and PUR-treated control. (C) Top: chromatogram showing the separation of monosome and polysome fractions. Middle: distribution of Actin mRNA across all fractions in WT and unzip mutant virus. Bottom: distribution of HCV RNA across all fractions in WT virus and unzip mutant virus. (D) Graphic showing the proposed pk1 acting mechanism.

    Journal: Cell reports

    Article Title: A ribosome-bound pseudoknot in the HCV coding region stimulates viral growth by tuning viral translation

    doi: 10.1016/j.celrep.2025.116739

    Figure Lengend Snippet: (A) Workflow of polysome fractionation and RNA quantification for HCV-transfected cells. (B) Top: chromatogram showing the separation of monosome and polysome fractions. Middle: distribution of Actin mRNA across all fractions in WT and PUR-treated control. Bottom: distribution of HCV RNA across all fractions in WT virus and PUR-treated control. (C) Top: chromatogram showing the separation of monosome and polysome fractions. Middle: distribution of Actin mRNA across all fractions in WT and unzip mutant virus. Bottom: distribution of HCV RNA across all fractions in WT virus and unzip mutant virus. (D) Graphic showing the proposed pk1 acting mechanism.

    Article Snippet: 3 × 10 6 Huh7.5 cells were plated in a 10 cm dish and transfected with 15.5 μg of full-length HCV RNA or mutant RNA using Mirus mRNA lipid transfection reagent (MIR-2250) according to the manufacturer’s protocol.

    Techniques: Fractionation, Transfection, Control, Virus, Mutagenesis

    (A) Workflow for identifying pk1-like elements across RNA virus genomes. (B) Top: pie chart summarizing the family distribution of input viruses. Middle: pie chart showing the family distribution of viruses identified after step 2. Bottom: pie chart displaying the family distribution and location of pk1-like elements after step 3. (C) Examples of high-confidence pk1-like elements located near viral protein boundaries. (D) Left: secondary structure representation of a pk1-like motif in Simian pegivirus and the design of the unzip mutant. Right: translation luciferase activity illustrating the function of pk1-like element in translation elongation, measured at 2 h post-transfection. Construct design is shown on the right. Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001). (E) AlphaFold3 prediction of tertiary structures for pk1, pk1-like elements, and a canonical frameshifting pseudoknot. The corresponding secondary structures derived from the tertiary models are shown below.

    Journal: Cell reports

    Article Title: A ribosome-bound pseudoknot in the HCV coding region stimulates viral growth by tuning viral translation

    doi: 10.1016/j.celrep.2025.116739

    Figure Lengend Snippet: (A) Workflow for identifying pk1-like elements across RNA virus genomes. (B) Top: pie chart summarizing the family distribution of input viruses. Middle: pie chart showing the family distribution of viruses identified after step 2. Bottom: pie chart displaying the family distribution and location of pk1-like elements after step 3. (C) Examples of high-confidence pk1-like elements located near viral protein boundaries. (D) Left: secondary structure representation of a pk1-like motif in Simian pegivirus and the design of the unzip mutant. Right: translation luciferase activity illustrating the function of pk1-like element in translation elongation, measured at 2 h post-transfection. Construct design is shown on the right. Data are represented as mean ± SD of three biological replicates. Statistical significance was determined using an unpaired Student’s t test with equal variance (** p < 0.01, *** p < 0.001, and **** p < 0.0001). (E) AlphaFold3 prediction of tertiary structures for pk1, pk1-like elements, and a canonical frameshifting pseudoknot. The corresponding secondary structures derived from the tertiary models are shown below.

    Article Snippet: 3 × 10 6 Huh7.5 cells were plated in a 10 cm dish and transfected with 15.5 μg of full-length HCV RNA or mutant RNA using Mirus mRNA lipid transfection reagent (MIR-2250) according to the manufacturer’s protocol.

    Techniques: Virus, Mutagenesis, Luciferase, Activity Assay, Transfection, Construct, Derivative Assay